AdaptHealth Corp. (NASDAQ:AHCO) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of AdaptHealth Corp. (NASDAQ:AHCO) have received a consensus rating of “Moderate Buy” from the six analysts that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $11.67.

A number of brokerages recently commented on AHCO. UBS Group dropped their price target on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. Canaccord Genuity Group reduced their target price on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, November 6th. Robert W. Baird reduced their price objective on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research note on Wednesday, November 6th. Royal Bank of Canada reduced their price target on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a research report on Tuesday, November 19th. Finally, Truist Financial lowered their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, November 15th.

Insider Buying and Selling

In other news, COO Shaw Rietkerk sold 25,000 shares of the business’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $11.24, for a total transaction of $281,000.00. Following the sale, the chief operating officer now owns 212,611 shares in the company, valued at approximately $2,389,747.64. The trade was a 10.52 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 4.43% of the stock is owned by insiders.

Institutional Investors Weigh In On AdaptHealth

Hedge funds have recently added to or reduced their stakes in the stock. Cornercap Investment Counsel Inc. raised its holdings in AdaptHealth by 2.8% in the 2nd quarter. Cornercap Investment Counsel Inc. now owns 46,706 shares of the company’s stock worth $467,000 after acquiring an additional 1,254 shares during the last quarter. SummerHaven Investment Management LLC raised its stake in shares of AdaptHealth by 2.7% in the second quarter. SummerHaven Investment Management LLC now owns 57,645 shares of the company’s stock worth $576,000 after purchasing an additional 1,503 shares during the last quarter. Public Sector Pension Investment Board raised its stake in shares of AdaptHealth by 1.2% in the second quarter. Public Sector Pension Investment Board now owns 171,877 shares of the company’s stock worth $1,719,000 after purchasing an additional 2,060 shares during the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of AdaptHealth by 8.1% during the second quarter. The Manufacturers Life Insurance Company now owns 39,440 shares of the company’s stock valued at $394,000 after purchasing an additional 2,959 shares in the last quarter. Finally, Mutual of America Capital Management LLC boosted its position in shares of AdaptHealth by 23.8% during the third quarter. Mutual of America Capital Management LLC now owns 15,893 shares of the company’s stock valued at $178,000 after buying an additional 3,052 shares during the last quarter. 82.67% of the stock is owned by institutional investors.

AdaptHealth Stock Up 0.3 %

AHCO opened at $9.72 on Friday. The company’s 50-day moving average price is $10.29 and its two-hundred day moving average price is $10.45. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. AdaptHealth has a twelve month low of $6.43 and a twelve month high of $11.90. The stock has a market cap of $1.31 billion, a price-to-earnings ratio of -5.89, a PEG ratio of 1.34 and a beta of 1.10.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.02). The firm had revenue of $805.90 million for the quarter, compared to the consensus estimate of $809.32 million. AdaptHealth had a negative net margin of 6.57% and a positive return on equity of 9.62%. AdaptHealth’s revenue for the quarter was up .2% on a year-over-year basis. During the same period last year, the company posted $0.19 earnings per share. As a group, equities analysts expect that AdaptHealth will post 0.88 earnings per share for the current year.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.